Health Sciences and Wellbeing

The global COVID-19 pandemic has highlighted the complexities of the health science market. Discovering, developing, authorising and commercialising new pharmaceuticals or medical innovations involves large investment and requires fostering relationships across a very wide range of stakeholder audiences.

Our experienced global teams advise clients on the right strategies to navigate the complex regulatory health environment and build the relationships and communication content required to succeed.

Health and wellbeing is a very personal issue and trust and reputation are key to consumers. We develop tailored strategies and content that reflect the unique requirement of each client and the markets that they want to address.

SEC Newgate UK

Insights from COP27 - Round Up and What's Next?

November 23, 2022